The effect of PPARγ agonists on cellular apoptosis is also variable, with increased apoptosis in some cancer cells [28-30] and none in others [31], which might be due to modulation of the signaling molecules by PPARγ ligands in various cancer pathways. Here, PPARG is linked to cancer.